Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Weekly Deals, The Week Ending January 26, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Pharos Capital Group, LLC Behavior Care Specialists N/A Biotechnology Acquirer Target Price Biogen Inc. KPT-350 $10 million DanDrit Biotech USA, Inc. Enochian Biopharma Inc. N/A Celgene... Read More »
Healthcare M&A Held Steady in 2017
Healthcare merger and acquisition activity held steady in the fourth quarter of 2017. Compared with the third quarter, deal volume increased 1%, to 377 transactions. Deal volume was lower than the same quarter in 2016, down 3%. Combined spending reached $114.4 billion, up 166% compared with the $43.1 billion spent in the previous quarter, according to HealthCareMandA.com. Fourth quarter deal value was 197% higher than the $38.6 billion spent in Q4:16. Health Care M&A Market – Deal Volume by Sector Q4:17 Q3:17 Q4:16 Sector Deals Deals Change Deals Change Services Behavioral Health Care 12 14 -14% 10 20% Home Health & Hospice 13 12 8% 24 -46% Hospitals 21 15 40% 23 -9%... Read More »
Deal of the Week: Aurora Cannabis/CanniMed Therapeutics
Canada’s cannabis industry is consolidating. Aurora Cannabis Inc. (OTCQX: ACBFF), the country’s second largest producer of cannabis and cannabis oil, is acquiring Saskatoon, Saskatchewan-based CanniMed Therapeutics Inc. (TSX: CMED) for approximately C$1.1 billion (US$893,343,000) in an all-stock offer. CanniMed bills itself as an international plant biopharmaceutical company with 17 years of pharmaceutical cannabis cultivation experience. The impending legalization of marijuana that is expected to become law in July 2018 is pushing marijuana producers to lock down growers who can help keep up with the expected demand. This acquisition is the largest in the global marijuana... Read More »Health Care M&A Weekly Deals, The Week Ending January 19, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Context Therapeutics Worldwide rights to Apristor N/A eHealth Acquirer Target Price Change Healthcare National Decision Support Company N/A Elsevier Via Oncology N/A eHealth, Inc. Health, Wealth and Life... Read More »
Deal of the Week: Elsevier/Via Oncology
Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked. Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals. Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the... Read More »
New Buyers Move in to Home Health & Hospice
The Home Health & Hospice sector is poised for big deals in 2018. As the healthcare industry shifts inexorably toward value-based reimbursement models, this sector has become the “go-to” care protocol to help drive down costs and to keep patients out of institutions. However, the pressures that existed in 2017 are still present in 2018, and even amplified now. Mark Kulik, managing director at The Braff Group, recently gave us his view of the market. Not only will the rate of M&A activity accelerate, new buyers will enter the market. “Ten years ago, people stayed in their lane. Today, we’re going out to a wider range of buyers, such as long-term care and... Read More »
Stat of the Week: Hospital M&A up 40% in Q4:17
Hospital M&A activity accelerated in the fourth quarter of 2017. The number of hospital acquisitions rose to 21 in the fourth quarter, up 40% from the 15 publicly announced acquisitions in the third quarter of 2017. Compared with the same quarter in 2016, which posted 23 transactions, activity was down 9%. None of the transactions disclosed a purchase price in the third quarter of 2017. Four of the deals disclosed prices, for a combined total of $2.82 billion. None of the transactions in the third quarter disclosed a price, although the fourth quarter of 2016 posted a total of $2.31 billion. The largest deal in the quarter was UnitedHealth Group’s (NYSE: UNH) $2.8 billion acquisition... Read More »
New MainStream Adds On to Platform Companies
The recent crop of healthcare services platforms owned by New MainStream Capital is moving to the add-on stage. Last week brought two acquisition announcements from Omni Eye Services and CORDENTAL Group. Both companies were acquired in 2017. New MainStream committed $25 million in equity capital to buy CORDENTAL in March 2017. The Cincinnati-based company is a dental support organization that provides business support services to affiliated dental practices in the Mid-Atlanta, Midwestern and Southeastern regions. Omni Eye Services, based in Iselin, New Jersey, is an optometric referral practice providing a full range of specialty services for the advanced treatment of eye diseases. No... Read More »
Allscripts Adds Practice Fusion
Allscripts Healthcare Solutions (NASDAQ: MDRX) is back in buying mode. The healthcare technology company announced two deals back in August 2017, picking off McKesson’s (NYSE: MCK) hospital and health IT portfolio for $185 million, and then NantHealth’s (NASDAQ: NH) electronic health record (EHR) assets for an undisclosed price. This time, the target is Practice Fusion, a Silicon Valley startup focused on creating affordable certified cloud-based EHR systems for small, independent physician practices. As small as that market may seem, the company now supports 30,000 ambulatory practices and 5 million patient visits per month. The deal is a strategic one for Allscripts,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
